FIELD: organic chemistry, medicine, endocrinology. SUBSTANCE: invention relates to the novel biologically active compound (±)-cis-3-(2'-benzimidazolyl)-1,2,2-tri- methylcyclopentane carboxylic acid eliciting sugar-reducing and anti- diabetogenic effect. EFFECT: valuable medicinal properties of compound. 4 tbl, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL ANTIDIABETIC COMPOSITION BASED ON (+)-CIS-3-(1H-BENZIMIDAZOL-2-YL)-1,2,2-TRIMETHYLCYCLOPENTANE CARBOXYLIC ACID | 2016 |
|
RU2624872C1 |
| 3-(1H-BENZIMIDAZOL-2-YL) -1,2,2-TRIMETHYL CYCLOPENTANCARBONIC ACID WITH CARDIOPROTECTIVE ACTIVITY | 2017 |
|
RU2645356C1 |
| METHOD OF CORRECTION OF STREPTOZOTOCIN-INDUCED DIABETES MELLITUS IN RATS USING A HETEROCYCLIC AMIDE-BASED DRUG | 2018 |
|
RU2687979C1 |
| ISONICOTINOYLHYDRAZIDE PHTHALATE AS ANTIDIABETIC AGENT | 2006 |
|
RU2331418C2 |
| COMBINATION FOR TREATMENT OF DIABETES AND COMPLICATIONS THEREOF | 2011 |
|
RU2451506C1 |
| ANTIDIABETIC AGENT | 2001 |
|
RU2195300C1 |
| METHOD OF TREATING HYPERGLYCAEMIA | 2017 |
|
RU2739255C2 |
| HAEMORHEOLOGIC AGENT CAPABLE OF REDUCING INSULING RESISTANCE AND RESTORING BODY TOLERANCE TO GLUCOSE AND PHARMACEUTICAL COMPOSITION BASED ON SAID AGENT | 2007 |
|
RU2386634C2 |
| METHOD FOR PRIMARY TREATMENT OF COMBINED WOUNDS USING PHARMACEUTICAL COMPOSITION BASED ON BIOPOLYMER OF CHITOSAN | 2024 |
|
RU2830804C1 |
| AGENT AND METHOD OF TREATING DIABETES MELLITUS | 2014 |
|
RU2545765C1 |
